“I see BLUD as possibly being bought for $27/share. If that’s true, then there’s not much upside on this, unless the deal falls thru. Do you have info on the buyout not completing? I see a claim filed against them (The Law Firm of Levi & Korsinsky, LLP Notifies Shareholders of Claims of Breaches of Fiduciary Duty Against the Board of Immucor, Inc. in Connection With Takeover by TPG Capital).”
That is most likely the reason the stock has retreated a bit from its high. I do not usually look at the fundamental reasons the stock has been pulling back. However after looking it over In retrospect it might of been best to forgo this trade.
Lets see how it works out. Its always a good idea to investigate my recommendations with your own methods. I also recommend that with my sports plays.